Surgery to improve survival in early-stage spread breast cancer
Part of Cancer, Skin clinical trials.
This study tests whether surgery to remove cancer spots can help people with breast cancer that has spread to a few places live longer. You would receive standard cancer medicines plus surgery if you qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Breast cancer confirmed by biopsy or tissue sample
- Cancer has spread to 5 or fewer spots in 3 or fewer organs
- Healthy enough to tolerate surgery and chemotherapy (ECOG score 0–2)
- Not already had surgery on your original breast tumor
- No signs of immediate organ failure from cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining surgery or strong focused radiation with standard treatment can help people whose HER2-positive breast cancer has spread to a few spots (5 or fewer) in the body, but not the brain. It's for patients whose cancer is stable after at least 3 months of first-line therapy.
This study tests a local (targeted) approach for breast cancer that has spread to the liver. It looks at whether treating liver metastases with planned liver surgery, along with standard cancer treatment before and after, can improve outcomes.
This trial tests whether treating just the few spots where breast cancer has spread (called oligometastases) with radiation or surgery can help control the disease. It is for people whose cancer has spread to 3 or fewer places, each small in size, and who are healthy enough for local treatments.
This trial compares a more direct local treatment (targeting a small, limited spot) versus a comfort-focused palliative approach for breast cancer that has spread only to one side of the upper arm bone or breastbone area. It aims to see which approach works better while keeping side effects manageable.
This trial compares having surgery to remove the breast tumor versus not having surgery for women whose breast cancer has spread only to the bone (and not to other organs). It aims to see if removing the primary tumor improves outcomes.
This Phase 2 study tests whether treating a small number of metastatic spots with a local approach (like targeted radiation, surgery, or ablation) can help people with ER/PR-positive breast cancer. It aims to help when the cancer has spread only to a few areas and has not significantly worsened after initial whole-body treatment.
Hear when a new Survival Outcomes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.